Please use this identifier to cite or link to this item:
http://publications.jrc.ec.europa.eu/repository/handle/JRC113789| Title: | Development and dosimetry of Pb-203 / Pb-212 labeled PSMA ligands – Bringing “the Lead” into PSMA-Targeting Alpha Therapy? |
| Authors: | KRATOCHWIL CLEMENS; DOS SANTOS JOSE CARLOS; LEHNERT WENCKE; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; HABERKORN UWE; KOPKA KLAUS; MIER WALTER |
| Citation: | NUKLEARMEDIZIN-NUCLEAR MEDICINE vol. 58 no. 2 p. 146 |
| Publisher: | SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN |
| Publication Year: | 2019 |
| JRC N°: | JRC113789 |
| ISSN: | 0029-5566 (online) |
| URI: | https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0039-1683594 http://publications.jrc.ec.europa.eu/repository/handle/JRC113789 |
| DOI: | 10.1055/s-0039-1683594 |
| Type: | Articles in periodicals and books |
| Abstract: | The development of a prostate-specific membrane antigen (PSMA)-ligand for labeling with different radioisotopes of lead and the approximation of the dosimetry of a simulated Pb-212 based alpha-therapy by using its Pb-203 imaging analogue. |
| JRC Directorate: | Nuclear Safety and Security |
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.